Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, Granta Park, Cambridge CB21 6GP, U.K.
AstraZeneca, R&D, Antibody Discovery & Protein Engineering, Milstein Building, Granta Park, Cambridge CB21 6GH, U.K.
Emerg Top Life Sci. 2021 Nov 12;5(5):601-608. doi: 10.1042/ETLS20200331.
Affinity maturation is a key technique in protein engineering which is used to improve affinity and binding interactions in vitro, a process often required to fulfil the therapeutic potential of antibodies. There are many available display technologies and maturation methods developed over the years, which have been instrumental in the production of therapeutic antibodies. However, due to the inherent limitations in display capacity of these technologies, accommodation of expansive and complex library builds is still a challenge. In this article, we discuss our recent efforts in the affinity maturation of a difficult antibody lineage using an unbiased approach, which sought to explore a larger sequence space through the application of DNA recombination and shuffling techniques across the entire antibody region and selections using ribosome display. We also highlight the key features of several display technologies and diversification methods, and discuss the strategies devised by different groups in response to different challenges. Particular attention is drawn to examples which are aimed at the expansion of sequence, structural or experimental diversity through different means and approaches. Here, we provide our perspectives on these methodologies and the considerations involved in the design of effective strategies for the directed evolution of antibodies.
亲和力成熟是蛋白质工程中的一项关键技术,用于提高体外的亲和力和结合相互作用,这是实现抗体治疗潜力的常用过程。多年来已经开发出许多可用的展示技术和成熟方法,这些技术对于生产治疗性抗体起到了重要作用。然而,由于这些技术在展示容量方面的固有局限性,仍然难以适应庞大而复杂的文库构建。在本文中,我们讨论了我们最近使用无偏方法对一种困难的抗体系进行亲和力成熟的努力,该方法试图通过在整个抗体区域应用 DNA 重组和洗牌技术以及使用核糖体展示进行选择来探索更大的序列空间。我们还强调了几种展示技术和多样化方法的关键特征,并讨论了不同组针对不同挑战制定的策略。特别关注旨在通过不同手段和方法扩展序列、结构或实验多样性的例子。在这里,我们提供对这些方法学的看法,以及在设计用于抗体定向进化的有效策略时涉及的考虑因素。